EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Feasibility of Using Population Pharmacokinetics‐Based Virtual Control Groups in Organ Impairment Studies

Islam R Younis iD, Fan Wang, Ahmed A Othman iD

The Journal of Clinical Pharmacology · 2024-06 · 64 (6) · 713-718

DOI: 10.1002/jcph.2410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, online erschienen am 12.02.2024. Verfasst von Islam R Younis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gilead Sciences, Inc., Foster City, CA, USA. Hauptthemen laut MEDLINE: Feasibility Studies, Area Under Curve. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This work aimed to assess the feasibility of using population pharmacokinetics (popPK) to generate virtual healthy control groups in organ impairment studies. Data from 11 organ impairment studies containing 18 organ impairment arms and 13 healthy control groups across 7 drugs were analyzed. Area under the concentration‐time curve (AUC) and maximum concentration (C max ) were calculated from popPK‐simulated individual concentration‐time profiles for participants in the healthy control groups, accounting for the participant's specific covariate(s) (N = 1000 replicates). The AUC and C max geometric mean ratios (GMRs; simulated healthy control/observed healthy control and observed organ impairment/simulated healthy control) were calculated. The simulated healthy control group geometric mean exposures were within 30% of the observed geometric mean exposures in 8 of the 11 studies (73%). The number of organ impairment arms for which the observed GMR (observed organ impairment/observed healthy control) and median of simulation‐based GMRs (observed organ impairment/simulated healthy control) for AUC and C max being within the same fold change were 12 (67%) and 13 (72%) arms, respectively. The number of organ impairment arms for which the median of simulation‐based AUC and C max GMRs were within the 90% confidence interval of the observed GMRs were 14 (72%) and 15 (83%), respectively. Poor concordance was observed for 1 drug (3 arms), where healthy participants' data were not incorporated in the popPK model. This work supports using popPK‐based virtual control groups in organ impairment studies. Subsequent work should aim to establish best practices for constructing popPK‐based virtual control groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Feasibility StudiesArea Under CurveHumansModels, BiologicalComputer SimulationPharmacokineticsMaleControl GroupsFemaleAdultPharmaceutical Preparations

Stichwörter der Autor:innen

hepatic impairmentpharmacokineticspopulation pharmacokineticsrenal impairmentvirtual control group

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Gilead Sciences, Inc., Foster City, CA, USA.
  • College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.

ORCID-Profile: Islam R Younis, Ahmed A Othman

Zitieren

APA

Younis, I. R., Wang, F., & Othman, A. A. (2024). Feasibility of Using Population Pharmacokinetics‐Based Virtual Control Groups in Organ Impairment Studies. The Journal of Clinical Pharmacology, 64(6), 713-718. https://doi.org/10.1002/jcph.2410

Vancouver

Younis IR, Wang F, Othman AA. Feasibility of Using Population Pharmacokinetics‐Based Virtual Control Groups in Organ Impairment Studies. The Journal of Clinical Pharmacology. 2024;64(6):713-718. doi:10.1002/jcph.2410

BibTeX
@article{Younis2024,
  author = {Younis, Islam R and Wang, Fan and Othman, Ahmed A},
  title = {Feasibility of Using Population Pharmacokinetics‐Based Virtual Control Groups in Organ Impairment Studies},
  journal = {The Journal of Clinical Pharmacology},
  year = {2024},
  volume = {64},
  number = {6},
  pages = {713--718},
  doi = {10.1002/jcph.2410}
}
Kostenlos starten →